LOVASTATIN vs LUMASIRAN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LOVASTATIN vs LUMASIRAN: Safety Overview
| Metric | LOVASTATIN | LUMASIRAN |
|---|---|---|
| Total FAERS Reports | 1,387 | 279 |
| Deaths Reported | 204 | 15 |
| Death Rate | 14.7% | 5.4% |
| Hospitalizations | 287 | 99 |
| Average Patient Age | 60.2 yrs | 43.3 yrs |
| % Female Patients | 55.9% | 72.7% |
| FDA Approval Date | Apr 14, 2006 | Nov 23, 2020 |
| Manufacturer | Preferred Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Discontinued | Prescription |